Importantly, pilot clinical studies demonstrated that vitamin D supplementation can decrease hepcidin levels in healthy volunteers (Bacchetta et al., 2014) and early stage CKD patients (Zughaier et al., 2014). The gene discussed is HAMP; the disease is chronic kidney disease.